{"id":1068350,"date":"2022-09-24T02:00:01","date_gmt":"2022-09-24T06:00:01","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/belite-bio-announces-late-breaking-presentation-at-the-american-academy-of-ophthalmology-2022-annual-meeting\/"},"modified":"2024-08-18T11:46:11","modified_gmt":"2024-08-18T15:46:11","slug":"belite-bio-announces-late-breaking-presentation-at-the-american-academy-of-ophthalmology-2022-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/belite-bio-announces-late-breaking-presentation-at-the-american-academy-of-ophthalmology-2022-annual-meeting.php","title":{"rendered":"Belite Bio Announces Late-Breaking Presentation at the American Academy of Ophthalmology 2022 Annual Meeting"},"content":{"rendered":"<p><![CDATA[SAN DIEGO, Sept.  23, 2022  (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinical stage biopharmaceutical drug development company targeting currently untreatable eye diseases, today announced that the 1-year interim data from the 2-year Phase 1b\/2 trial of LBS-008 in adolescent STGD1 will be presented at the \u201cLate Breaking Development\u201d session at the American Academy of Ophthalmology Annual Meeting (AAO 2022) being held September 30 \u2013 October 3, 2022 in Chicago.]]><\/p>\n<p>Excerpt from:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/09\/23\/2521753\/0\/en\/Belite-Bio-Announces-Late-Breaking-Presentation-at-the-American-Academy-of-Ophthalmology-2022-Annual-Meeting.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Belite Bio Announces Late-Breaking Presentation at the American Academy of Ophthalmology 2022 Annual Meeting\">Belite Bio Announces Late-Breaking Presentation at the American Academy of Ophthalmology 2022 Annual Meeting<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Excerpt from: Belite Bio Announces Late-Breaking Presentation at the American Academy of Ophthalmology 2022 Annual Meeting <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/belite-bio-announces-late-breaking-presentation-at-the-american-academy-of-ophthalmology-2022-annual-meeting.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068350","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068350"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068350"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068350\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}